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2Abstract14
The elongation of poly(A) tails in cytoplasm is essential for oogenesis and early 15
embryogenesis in Xenopus laevis.  mGLD-2 is a mouse homologue of Xenopus16
cytoplasmic poly(A) polymerase xGLD-2.  We found an association of mGLD-2 with17
cytoplasmic polyadenylation components, CPEB and CPSF described in Xenopus18
oocytes.  To clarify the role of mGLD-2 in mouse, we produced an mGLD-2 disrupted19
mouse line by homologous recombination.  In spite of the ubiquitous expression of 20
mGLD-2, the disrupted mice were apparently normal and healthy.  Moreover, it was 21
demonstrated that mGLD-2 disruption did not affect the poly(A) tail elongation in22
oocytes using reporter RNAs. Coincide with these observations, the maturation of the 23
oocytes was normal and the mice were fertile.  Thus mGLD-2 is dispensable for24
full-term development and oogenesis.  Our results also indicate that there is another 25
source of cytoplasmic poly(A) polymerase in mouse.26
27
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3Introduction31
The addition of mRNA poly(A) tails initially occurs in the eukaryotic nucleus.  The 32
processing of the mRNA precursors is one of the post-transcriptional gene regulations, 33
because the length of the poly(A) tail is implicated in various aspects of mRNA 34
metabolism, including the transport of mRNAs into the cytoplasm, mRNA stability, and 35
translational control of mRNA [1].  However, the poly(A) tail is not exclusively added36
to mRNAs in the nucleus but also found to take place in the cytoplasm.  The 37
elongation of the poly(A) tail length in the cell cytoplasm are essential for normal 38
gametogenesis [2-4] and early embryogenesis [5]. For example, meiotic maturation of 39
Xenopus and mouse oocytes has been reported to require cytoplasmic polyadenylation 40
of c-mos and cyclin B1 mRNAs for synthesis of the proteins [6, 7].  41
Several poly(A) polymerases responsible for the cytoplasmic polyadenylation are 42
identified.  Yeast Cid13 participates in DNA replication and genome maintenance,43
specifically targeting suc22 mRNA that encodes a subunit of ribonucleotide reductase44
[8], while yeast Cid1 and C. elegans GLD-2 targets a subset of mRNAs controlling the45
inhibition of mitosis and entry into meiosis [4, 9].  In mammals, we have reported that 46
a testis specific cytoplasmic poly(A) polymerase, TPAP, elongates a poly(A) tail of 47
mRNAs essential for spermatogenesis [3].  However, ploy(A) polymerases that may48
4function in somatic tissues are not known in mammals.  Recently, we cloned the49
GLD-2 mouse homolog, mGLD-2, by PCR using cDNA prepared from an unfertilized50
mouse oocyte library as a template [10]. The mGLD-2 was expressed throughout the51
body and localized both in the nucleus and cytoplasm in somatic cells [10].  However,52
in oocytes in metaphase I and II stage after germinal vesicle breakdown, mGLD-2 was53
found exclusively in the cytoplasm [10].  mGLD-2 also possessed a CPE (cytoplasmic 54
polyadenylation element)-specific polyadenylation activity in the ooplasm and a55
knockdown experiment caused the impairment of oogenesis [10].  Thus mGLD-2 was56
suggested to control the translation of specific proteins in oogenesis.  In the present57
experiment, we produced an mGLD-2 gene disrupted mouse line to clarify the role of58
mGLD-2.  Here, we report the effects of mGLD-2 on polyadenylation activity in 59
somatic cells and oocytes together with the effects on live mouse including oogenesis.  60
61
Materials and methods62
GST pull-down assay 63
Recombinant proteins were synthesized in vitro in the presence of 35S-labeled Met 64
(1000 Ci/mmol, MP biomedicals) by a TNT T7 Quick Coupled 65
Transcription/Translation system (Promega).  GST fusion proteins immobilized on 66
5glutathione–Sepharose gel (Amersham Biosciences) were mixed with 35S-labeled 67
protein in 50 mM Tris/HCl, pH 7.5, containing 150 mM NaCl, 5 mM EDTA, 0.5% 68
Nonidet P-40, and protease inhibitors for 1 h.  After the gel was washed five times 69
with the same buffer, proteins on the gel were treated with a Laemmli buffer, and 70
analyzed by SDS–PAGE.71
72
Generation of mutant mice lacking mGLD-273
Genomic clones encoding mGLD-2 were isolated from a mouse 129/SvJ genomic74
DNA library in λFIXII (Stratagene) using 32P-labeled DNA fragments as probes.  Of75
the ten clones isolated, a clone, termed MGLD4, was used for construction of a76
targeting vector carrying a neomycin-resistance (neo) expression cassette flanked by a77
1.5- and 9.7-kbp genomic region of mGLD-2.  For negative selection, an HSV-TK (tk)78
cassette was inserted at the 5’-end of the targeting vector (Fig. 1C).  The construct was79
designed to replace a part of second exon and the whole third exon with the neo80
expression cassette.  Following electroporation of the targeting vector into D3 mouse81
ES cells, homologous recombinants were selected by using G418 and gancyclovir.  82
Ten ES cell clones containing the targeted mutation were selected from 186 clones, and83
injected into C57BL/6 mouse blastocysts.  Chimeric male mice were crossed to84
6C57BL/6 females (SLC Inc., Japan) to establish the heterozygous mutant lines.  All85
animal experiments were carried out according to the Guide for the Care and Use of86
Laboratory Animals in the University of Tsukuba.87
88
Blot hybridization89
Genomic DNA was prepared from the mouse tail, digested by BglII and PstI,90
separated by agarose gel electrophoresis, and transferred onto Hybond-N+ nylon91
membranes (Amersham Biosciences).  Total cellular RNA was prepared from liver92
using Isogen (Nippon Gene, Japan) [3].  The RNA samples were glyoxylated,93
separated by agarose gel electrophoresis, and transferred onto the nylon membranes.  94
The blots were probed by 32P-labeled DNA fragments, and analyzed by a BAS-1800II95
Bio-Image Analyzer (Fuji Photo Film, Japan).96
97
Antibodies and immunoblot analysis98
Affinity-purified anti-mGLD-2 antibody was prepared as described previously [10].  99
The antibody against β-tubulin was purchased from Sigma.  Mouse tissues were100
homogenized at 4°C in 20 mM HEPES/KOH, pH 7.5, containing 150 mM NaCl, 1 mM101
EDTA, 1.0% Triton X-100, 0.5% deoxycholate, 0.1% SDS.  Oocytes were lysed at102
74°C in 10 mM Tris/HCl, pH 8.0, containing 1.5 mM MgCl2, 10 mM KCl, 1.0% Triton103
X-100, 0.5% deoxycholate, 0.1% SDS.  Proteins in the supernatant solution were104
subjected to Western blot analysis.  The immunoreactive proteins were visualized by105
an ECL Western blotting detection kit (Amersham Biosciences).  106
107
Immunoprecipitation108
Nuclear extract of mouse liver was prepared as previously described [10].  Protein 109
A-agarose beads (50% slurry, Pierce), bound with the affinity purified anti-mGLD-2 110
antibody, were mixed with the nuclear extracts (0.5 mg protein), and then incubated at111
4°C overnight.  After centrifugation, the pellet was washed five times with the binding112
buffer, and then subjected to the measurement of polyadenylation activity.  113
114
Assay of polyadenylation activity115
Poly(A) polymerase activities were determined by measuring incorporation of AMP 116
from [α-32P]ATP (400 Ci/mmol, MP biomedicals) into oligo(A)12 RNA primer in the 117
presence of MnCl2 [10].  The reaction mixtures were sequentially spotted onto118
Whatman DE-81 paper, washed with 0.1 M phosphate buffer, pH 7.0, and then119
measured by liquid scintillation counting.  120
8121
Polymerase chain reaction (PCR)122
Total cellular RNAs were extracted from metaphase II-arrested oocytes using Isogen123
(Nippon Gene) [10].  For RT-PCR, first-strand cDNA was synthesized from total124
RNAs by a SuperScript III reverse transcriptase (Invitrogen) using oligo dT20 as a125
primer.  A portion of the synthesized cDNAs was subjected to PCR using specific126
primer sets.  A set of primers, 5’-TCGGCCCTTCGGCGTGGACG-3’ (sense) and127
5’-TGTAAGGACACAGCTCTAGAC-3’ (antisense), corresponding to the sequences in128
the first and third exons of mGLD-2, respectively, was used for assessment of the third129
exon replacement by neo.  For the PCR-based poly(A) test, total RNA from oocytes130
were ligated to a 32-mer RNA oligonucleotide,131
5’-UACGCAUCAUACGCUGUGGCGUACCUUGUA-3’ (60 pmol), and reacted at132
42C for 50 min with SuperScript II reverse transcriptase (Invitrogen), using a PAT1133
oligonucleotide, 5’-ACAAGGTACGCCACAGCGTATG-3’, as a primer.  A portion of134
the reaction mixture was subjected to first round PCR using a set of PAT1 and a135
gene-specific primer.  Second round PCR was carried out using a nested set of primers,136
PAT2, 5’-GGCTCGAGGTACGCCACAGCGTATGATG-3’, and another gene-specific137
primer.  Details of the PCR conditions, including other primer sequences are described138
9previously [10].139
140
RNA synthesis in vitro141
DNA fragments including the CPE/HEX and mutCPE/HEX of cyclin B1 mRNA142
were amplified by PCR from a mouse testis cDNA library [11] using primer sets,143
CYBP7/9 and CYBP8/9, respectively.  The following oligonucleotides were used as144
primers: CYBP7 (5’–AAGTCGACTTTTAATTTATACATCTGATATCAAG–3’),145
CYBP8 (5’–AAGTCGACTTTGGATTTATACATCTGATATCAAG–3’), and CYBP9146
(5’–TAAAGCTTTCCACCAATAAATTTTATTCAA–3’).  The PCR products were147
introduced between EGFP and 45 adenosine residues of a pEGFPA45 vector.  The148
resulting plasmids were linearized by cutting with BsmBI.  RNAs were synthesized149
with T3 polymerase using an mMESSAGE mMACHINE T3 Kit (Ambion).  150
151
Microinjection152
Oocytes at metaphase II stage were collected from the oviducts of female mice that153
had been superovulated by pregnant mare’s serum gonadotropin (5 units, ASKA154
Pharmaceutical, Japan) followed by human chorionic gonadotropin (5 units, ASKA155
Pharmaceutical) 48 h later.  A mixture of equal volumes of RNAs (1 mg/ml) and156
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TRITC-labeled dextran (50 μM) was injected into the oocytes using a Piezo-driven157
micromanipulator (Prime Tech Ltd., Japan).  Approximately 10 pl of the RNA solution158
was introduced into the oocytes.  The oocytes were incubated in drops of kSOM159
medium [10] covered with mineral oil (Sigma) at 37°C under 5% CO2 in air.  The160
oocytes were observed using an Olympus IX-70 inverted microscope equipped with a161
SPOT RT camera (Diagnostic Instruments).  The 16-bit digital images were analyzed162
by using a Metamorph software (Universal Imaging Corp.).163
164
Results and discussion165
Interaction of mGLD-2 with the cytoplasmic polyadenylation complex 166
GLD-2 in C. elegans encodes the catalytic moiety of a cytoplasmic poly(A) 167
polymerase (PAP) that is associated with a regulation of mitosis/meiosis decision and168
other germline events [4].  xGLD-2 from Xenopus is also known to function in 169
ooplasm which implies that cytoplasmic PAPs are fundamental factors to regulate the 170
translation of mRNA [12].  The most prominent and well investigated site for 171
cytoplasmic polyadenylation is the oocytes.  In Xenopus, the translational levels of the 172
mRNAs are controlled by xGLD-2 together with polyadenylation regulatory factors 173
such as CPEB (CPE-binding protein) and CPSF (cleavage and specificity factor)174
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during oogenesis and early embryogenesis [12].  We have already shown the CPE 175
(cytoplasmic polyadenylation element)-specific polyadenylation activity of mGLD-2176
[10].  To further investigate the roles of mGLD-2 in vitro, we produced recombinant 177
mGLD-2 and examined its association with various GST-tagged proteins included in 178
cytoplasmic polyadenylation machinery.  As shown in Fig. 1A, mouse CPEB1 [13]179
and cytoplasmic poly(A) binding protein 1, PABPC1 [14], interacted with mGLD-2.  180
CPEB2 [15], which is expressed in mouse testis was also found to interact with 181
mGLD-2.  To analyze the binding ability of mouse CPSF160 [16], a subunit of CPSF, 182
to mGLD-2, we produced GST-tagged mutant mGLD-2 (D215A), which has almost no 183
polyadenylation activity [10], and mixed it with recombinant CPSF160 (Fig. 1B).  This 184
was necessary due to the low yield of GST-tagged CPSF160 and mGLD-2.  Moreover, 185
the association of recombinant CPEB1, CPEB2, and PABPC1 with GST-tagged D215A 186
was also demonstrated (Fig. 1B).  These data indicate the involvement of mGLD-2 in 187
the regulation of mRNA translation by associating with the cytoplasmic 188
polyadenylation complex which is formed on the poly(A) tail.189
190
Production of mGLD-2-deficient mice191
Mutant mice lacking mGLD-2 were produced by homologous recombination in ES 192
12
cells, using a targeting vector containing neo and tk expression cassettes (Fig. 1C).  A 193
part of the second exon and the whole third exon were replaced by the neo cassette.  194
The genotypes of wild-type (mGLD-2+/+), heterozygous (mGLD-2+/-), and homozygous 195
(mGLD-2-/-) mice for the null mutation of mGLD-2 were identified by Southern blot 196
analysis of genomic DNA (Fig. 1D).  Mating of mGLD-2+/- male and female mice 197
yielded the expected Mendelian frequency of mGLD-2-/- mice (mGLD-2+/+ : mGLD-2+/- : 198
mGLD-2-/- = 10 (17%) : 34 (58%) : 15 (25%) for 59 offspring from 6 litters).  Both 199
mGLD-2-/- males and females were apparently normal in behavior, body size, and health 200
condition.  Northern blot analysis indicated the absence of mGLD-2 mRNA in the 201
liver of mGLD-2-/- mice (Fig. 1E).  Moreover, protein extracts of the mGLD-2-/- liver 202
completely lacked mGLD-2 (Fig. 1F).  These data demonstrate the successful gene 203
disruption of mGLD-2-/- in our mutant mouse line.  204
205
Analysis of mGLD-2-deficient somatic cells206
mGLD-2 localizes both in the nucleus and in the cytoplasm [10]. We prepared 207
mGLD-2 from the nuclear extract of mouse liver cells by immunoprecipitation and 208
assayed the polyadenylation activity.  As a result, it was demonstrated the 209
polyadenylation activity in mGLD-2+/- mice are about half that of the mGLD-2+/+ mice 210
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and disappeared in mGLD-2-/- mice (Fig. 2A).  However, when we observed the total 211
polyadenylation activity using nuclear or cytoplasmic extract, we could not find any 212
significant differences between mGLD-2+/- and mGLD-2-/- mouse extracts (Fig. 2B).  213
The results indicate that the disruption of mGLD-2 did not affect the overall poly(A) 214
length in the liver. 215
216
Analysis of mGLD-2-deficient oocytes217
We previously reported that over expression of mGLD-2 in mouse oocytes could 218
selectively elongate the poly(A) tail length of cyclin B1 and Mos mRNAs [10].  This 219
may indicate that mGLD-2 is involved in oogenesis by controlling the translation of key 220
factors.  Thus we next examined the effect of mGLD-2 disruption on oocytes.  221
Naturally, the expression of mGLD-2 was demonstrated to disappear totally in 222
mGLD-2-/- mouse oocytes in mRNA and also in protein levels (Figs. 3A and 3B).  223
However, as observed in the liver, no significant decrease in overall polyadenylation 224
activity was evident in mGLD-2-/- mouse oocytes (Fig. 3C).  For more detailed analysis, 225
we examined the change in poly(A) tail length of cyclin B1 and Mos mRNA by 226
amplifying the poly(A) tails by PCR using two primer sets described in the materials 227
and methods.  However, we could not find any significant difference in the poly(A) 228
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tails in germinal vesicle, metaphase I and metaphase II-stage oocytes from mGLD-2-/-229
mice (Fig. 3D).230
231
Noninvasive measurement of the cytoplasmic polyadenylation activity232
In order to quantify the CPE dependent polyadenylation activity in oocytes, we 233
produced synthetic EGFP RNA with 3’-UTR of cyclin B1 which contained CPE and 234
AAUAAA followed by a 45 bp length poly(A) tail (Fig. 4A).  Since, the elongation of 235
cyclin B1 poly(A) tail is reported to take place in metaphase I and II-stage oocytes [7], 236
we injected the reporter RNA into oocytes at metaphase II stage.  Six hours after the 237
introduction of the RNA, a tremendous increase of fluorescence from EGFP was 238
observed (Fig. 4B).  On the other hand, the oocytes did not become fluorescent when 239
the reporter RNA which contained mutated CPE was injected (Figs. 4A and 4B).   240
Using this system, we measured the cytoplasmic polyadenylation activity in mGLD-2 241
disrupted oocytes.  Different from our expectation, as shown in Figs. 4B and 4D, the 242
mGLD-2 null oocytes became fluorescent by the injection of the reporter RNA.  243
Concomitant with this observation, the elongation of the poly(A) tail was observed in 244
the reporter RNA including the CPE sequence (Fig. 4C). Reflecting the normal 245
cytoplasmic polyadenylation in mGLD-2 knockout mouse oocytes, the transition rate of 246
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mGLD-2-/- mouse oocytes from germinal vesicle to metaphase II stage in vitro was 247
comparable to that of mGLD-2+/- oocytes (+/–,80 ± 13%, n = 3; –/–,77 ± 11%, n = 3). 248
Moreover, the spindle formation in the mGLD-2 disrupted oocytes was normal when 249
oocytes were observed after staining with anti-β-tubulin antibody and Hoechst 33342250
(data not shown).  The lack of apparent phenotype was reassured by the normal251
number of pups obtained from mGLD-2-/- female mice (7.9 ± 3.0, n = 13) compared to 252
the mGLD-2+/- female mice (8.9 ± 2.7, n = 8) when mated with wild-type mice.  253
254
In Xenopus, there is a notion that xGLD-2 is the responsible enzyme for 255
CPE-dependent cytoplasmic polyadenylation, but this was not applicable in mouse since 256
mGLD-2 was indicated not to be an exclusive enzyme for the polyadenylation. In257
mammalian cells, six PAPs have been identified: canonical PAP (PAPI and PAPII) [17],258
TPAP [3], neo-PAP [18], PAP [19], GLD-2 [4], and nuclear-encoded mitochondrial259
PAP, mitoPAP [20].  These mammalian PAPs, except TPAP, GLD-2, and mitoPAP, are260
exclusively localized in the nucleus.  Nuclear PAP localizes in the cytoplasm during261
metaphase where the nuclear envelope disappears.  However, canonical PAP has been262
reported to be inactivated via phosphorylation by p34cdc2/cyclinB complex during263
metaphase [21].  Mitochondria is another source of PAP, but mitoPAP localizes only264
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inside the mitochondria [20].  Thus PAP that functions in cytoplasm is not known in 265
mouse except mGLD-2.  The result of our RNAi experiment suggested an important 266
role of mGLD-2 in mouse oocyte maturation [10].  Contrary to our expectation, we 267
could not find any phenotype in mGLD-2 deficient mice.  This might be a result of 268
some compensation effect (up regulation) of a yet unknown mouse cytoplasmic poly(A)269
polymerase.  However, the compensation was not effectively functional in the RNAi 270
experiment [10], which may relate to the nature of the sudden impairment of mGLD-2 271
activity in RNAi.272
Combining the results from other cases, where distinctive phenotypes are observed273
such as disruption of GLD-2 in C. elegans, Cid1 and Cid13 in yeast, [4, 8, 9, 22] and 274
testis specific PAP (TPAP) in mouse [3], the lack of phenotype in the mGLD-2275
disrupted mouse line may indicate the existence of a yet unknown cytoplasmic PAP.  276
We presume that it would be worth to quest a new cytoplasmic PAP to elucidate the277
regulation of mRNA translation leading to dramatize various characteristics of living278
cells.  279
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Figure Legend344
Figure 1345
Direct interaction of mGLD-2 with components in polyadenylation complex and 346
generation of mGLD-2-deficient mice.  (A) GST pull-down assays were carried out 347
using 35S-labeled mGLD-2 and each polyadenylation components fused with GST.  348
(B) GST pull-down assays were carried out using 35S-labeled polyadenylation349
components and mutant mGLD-2, D215A, fused with GST.  (C) Schematic 350
representation of the gene targeting strategy.  For detail, refer to the materials and 351
methods.  Restriction enzyme sites indicated are as follows: S, SacI; G, BglII; P, PstI; 352
X, XhoI, Sa; SalI.  (D) Southern blot analysis of genomic DNA from wild-type 353
(mGLD-2+/+, +/+), heterozygous (mGLD-2+/-, +/–) and homozygous (mGLD-2-/-, –/–) 354
mice.  Genomic DNA was digested by BglII and PstI, separated by agarose gel 355
electrophoresis, and subjected to Southern blot analysis using a 32P-labeled DNA 356
fragment (S-probe in panel C) as a probe.  The wild-type and targeted alleles yielded 357
4.7- and 5.5-kbp DNA bands, respectively.  (E) Northern blot analysis of total RNAs 358
from liver tissues.  Two forms (3.5 and 2.3 kbp) of mGLD-2 mRNA, distinguished by 359
the length of the 3’-untranslated region encoded by the same exon of the mGLD-2 gene, 360
were absent in mGLD-2-/- mouse liver.  G3PDH, glyceraldehyde-3-phosphate 361
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dehydrogenase.  (F) Western blot analysis of protein extracts from liver tissues.  362
Proteins (10 μg) were loaded in each lane and probed with affinity-purified 363
anti-mGLD-2 or anti-β-tubulin antibody.  The mGLD-2-/- mouse liver lacked mGLD-2 364
with the size of 54 kDa.  An asterisk indicates the location of a 51-kDa protein 365
nonspecifically immunoreactive with the anti-mGLD-2 antibody.366
367
Figure 2368
Polyadenylation activity in mGLD-2-/- mouse liver.  (A) Enzyme activity of 369
mGLD-2 in the liver nuclear extract.  Nuclear protein (0.5 mg) of mGLD-2+/+ (open370
circle), mGLD-2+/- (shaded circle), and mGLD-2-/- (closed circle) mice were 371
immunoprecipitated using affinity-purified anti-mGLD-2.   Polyadenylation activities 372
of the precipitation were monitored by measuring the incorporation of AMP from 373
[α-32P]ATP into oligo(A)12 primer.  (B) Total polyadenylation activity of nuclear and 374
cytoplasmic protein (4 μg) extracted from mGLD-2+/- (shaded column) and mGLD-2-/-375
(closed column) mouse liver.  Relative activities measured at 6 h are indicated as 376
means ± S.D., where n = 3.377
378
Figure 3379
24
Polyadenylation activity in mGLD-2-/- mouse oocytes.  (A) RT-PCR analysis of 380
total RNAs from metaphase II-stage oocytes.  No DNA band was detected in 381
mGLD-2-/- mice.  G3PDH, glyceraldehyde-3-phosphate dehydrogenase.  (B) Western 382
blot analysis of protein extracts from metaphase II-stage oocytes.  Proteins of oocytes 383
(50 cells per lane) were loaded in each lane and probed with affinity-purified 384
anti-mGLD-2 or anti-β-tubulin antibody.  (C) Total polyadenylation activity of protein 385
extracts (50 cells) from metaphase II-stage oocytes of mGLD-2+/- (shaded column) and 386
mGLD-2-/- (closed column) mice.  Relative activities measured at 6 h are indicated as 387
means ± S.D., where n = 4.  (D) The sizes of poly(A) tails of cyclin B1, Mos, and388
β-actin, as a negative control.  Total RNAs from the GV-, MI- and MII-stage oocytes 389
(50 cells) of mGLD-2+/- and mGLD-2-/- mouse were subjected to PCR-based poly(A) 390
test.  391
392
Figure 4393
Cytoplasmic polyadenylation activity of mGLD-2-/- mouse oocytes.  (A) Schematic 394
representation of the synthetic reporter RNAs.  EGFP open reading frame was fused to 395
48 bp of the cyclin B1 3’-UTR.  The polyadenylation hexanucleotide (AAUAAA), 396
CPE and poly(A) tail are indicated.  (B) Fluorescence images of mGLD-2+/- and 397
25
mGLD-2-/- mouse oocytes 6 h after the injection of the reporter RNAs.  TRITC-labeled 398
dextran was coinjected with the RNA to normalize the amount of RNA injected (D).  399
Scale bar = 100 μm.  (C) PCR-based poly(A) test of reporter RNAs injected into 400
mGLD-2+/- and mGLD-2-/- mouse oocytes.  Oocytes (8 cells) were subjected to the 401
analysis 6 h after the RNA injection.  (D) Quantification of cytoplasmic 402
polyadenylation activities of mGLD-2+/- and mGLD-2-/- mouse oocytes.  EGFP 403
fluorescence of the oocytes was measured at 2-h intervals, and was divided by that of 404
the TRITC-labeled dextran coinjected with the reporter RNA.  The highest intensity of 405
an oocyte after 6-h incubation was set at 100%.  Number of mGLD-2+/- oocytes 406
examined: 15 (n = 2) and 8 (n = 1) injected with CPE(-) and CPE(+) RNA, respectively.  407
Number of mGLD-2-/- oocytes examined: 17 (n = 2) and 10 (n = 1) injected with CPE(-) 408
and CPE(+) RNA, respectively.  The data indicate the means ± S.D.409
410
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